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Abstract
Introduction
More than 80% of all smokeless tobacco (ST) products in the world are consumed in South
Asia; yet little is known about their consumption behaviour, addictiveness, and toxic proper-
ties. This paper, for the first time, describes associations between salivary cotinine concen-
trations among ST users in Bangladesh and their socio-demographic characteristics and
tobacco use behaviours.
Methods
In a survey of ST users in Dhaka, Bangladesh, we purposively recruited 200 adults who
were non-smokers but consumed ST on a regular basis. In-person interviews were con-
ducted to obtain information about socio-demographic and ST use behaviours, and saliva
samples were collected to measure cotinine concentration. Simple and multiple linear
regression analyses were conducted to test associations between the log transformed sali-
vary cotinine concentration and other study variables.
Results
The geometric mean of cotinine concentration among ST users was 380ng/ml (GSD:2).
Total duration of daily ST use in months had a statistically significant association with cotin-
ine concentration. Other ST use characteristics including type and quantity of ST use, swal-
lowing of tobacco juice, urges and strength of urges and attempts to cut down on tobacco
use were not found to be associated with cotinine concentration in a multivariable model.
Conclusion
This is the first report from Bangladesh studying cotinine concentration among ST users
and it points towards high levels of addiction. This warrants effective tobacco control poli-
cies to help ST cessation and prevention.
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Introduction
Almost a fifth of world’s tobacco is consumed in smokeless form [1], mostly in South Asia.
Smokeless tobacco (ST) use is integral to South Asian culture, being incorporated in their tra-
ditional values, spirituality, beliefs, festivals, marriage ceremonies, lifestyle, rituals and popu-
lar entertainment [2–4]. Over 250 million people use ST products in South East Asia of
which 13% reside in Bangladesh [5]. In Bangladesh, 27.2% (25.9 million) adults, 26.4% (12.5
million) of men and 27.9% (13.4 million) of women, are current consumers of ST products
[6]. Thus ST use prevalence exceeds cigarette smoking among both men and women in this
population.
ST products are considered highly addictive due to their high nicotine concentration [7]. ST
products also contain carcinogenic substances like tobacco-specific N-nitrosamines (TSNAs)
leading to an increased risk of cancers of oral cavity, pharynx, and oesophagus. Increased risk
of cardiovascular disease mortality has also been observed among ST users [8]. ST consump-
tion during pregnancy is associated with low birth weight and stillbirths [1], [9].
A diverse range of ST products are available worldwide, varying in their composition, meth-
ods of preparation and consumption, and associated health risks. Khaini, Zarda and Gutkha
are popular in South and South-East Asia. In other parts of world, the most commonly used ST
products include Snus (Nordic countries and North America), Chimó (Venezuela), Nass
(Uzbekistan, Kyrgyzstan), Tambook (Sudan, Chad), and Snuff (Nigeria, Ghana, South Africa)
[10]. Depending on the type of ST product, nicotine content may vary, and therefore, measure-
ment of nicotine and its metabolites among ST users is important to understand the addictive
potential of ST products. Cotinine is a sensitive and specific quantitative indicator of the uptake
of nicotine over the past few days [11]. Its concentration in body fluids is determined by the
rate of nicotine metabolism and cotinine clearance [12], [13]. Although individual variation
might exist in salivary cotinine concentrations because of such parameters, it is still an impor-
tant indicator of nicotine intake and a predictor of nicotine dependence. A few US-based stud-
ies have explored association between cotinine concentration among ST users and their
tobacco consumption behaviours. These included years of ST use, quantity, total dipping time,
swallowing of tobacco juices, previous quit attempts, and demographic factors, including age,
marital status, and occupation [12–15]. However, such evidence is lacking among ST users in
South Asia–a region with the highest ST disease burden. Due to the distinct nature of ST prod-
ucts consumed in South Asia, it is important to study factors associated with cotinine concen-
tration among ST users in this region. In this study we examined association between salivary
cotinine concentration among ST users in Bangladesh and their socio-demographic character-
istics and tobacco use behaviours. To our knowledge, this is the first study reporting salivary
cotinine concentration among ST users in Bangladesh.
Methods
Study design and study participants
A cross-sectional survey was carried out recruiting a purposive sample of ST consumers in
Dhaka, Bangladesh.
We recruited 200 current ST users aged 18 years or older, who were non-smokers (either
never smokers or former smokers who have not smoked for at least past one year). Current ST
users were defined as those using ST products for at least one year, with a minimum of one can
or pouch of ST used per week. Those with a history of other substance abuse or psychiatric ill-
nesses were excluded. Participants were recruited purposively from two urban cities in Dhaka,
namely Mohakhali and Mirpur, through convenience sampling techniques, including snowball
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sampling and community referrals. Trained field researchers recruited participants by visiting
houses in these communities, at community gatherings, ST shops, and through personal refer-
rals. Researchers first approached local leaders in the study areas and people buying ST prod-
ucts from shops and explained the study objectives. Local leaders and ST users gave references
of their relatives, friends, and neighbours who use ST. We recruited male and female ST users
in equal proportion. Taka 200 (GBP 1.5) was paid to respondents as opportunity cost of their
time. Interviews and saliva sample collections were conducted at ST users’ home or other
mutually convenient place, such as their workplace. Informed written consent was obtained
from all study participants. Data were collected between September and November 2014. This
study was approved by the Bangladesh Medical Research Council (BMRC) and the Research
Governance Committee at the University of York, UK.
Measures
A survey containing a set of questionnaires was administered by trained interviewers to collect
information on the; (a) socio-demographic characteristics, including age, sex, education, and
household asset ownership; and b) tobacco use behaviours, i.e. quantity (in grams) of ST used
per week, number of chews/dips per day (DPD) in the past week, duration of ST use in months,
type of ST products used, swallowing of tobacco juices, urge and strength of urge to use ST,
Fagerström Test for Nicotine Dependence (FTND- ST), Tobacco Dependence Screener (TDS),
attempt to cut down on ST use in the past, and past smoking status. ST products are generally
sold in cans and packets that vary in weights. We standardized our quantity estimates by show-
ing participants cans and packets of 10, 20 and 30 grams. We asked the respondent to point
out to the size of cans and packets they generally buy and how long does it take for them to
consume these. From this information, we estimated the amount of ST in grams consumed
during an average week.
Measures of dependence, FTND-ST and TDS were adapted through the process of transla-
tion and back-translation, and cross-cultural validation for use in Bangladeshi culture and lan-
guage. Translation and back-translation was done by bilingual and bicultural translators
outside the research team [16].
To measure cotinine concentration, saliva samples were collected from all participants at
the interviews using Salivette, oral swab and swab storage tube. Saliva samples were taken at
least 30 minutes after eating, drinking or taking medication. A sterile cotton swab was tipped
under the tongue without touching, and was left there until it became soggy. This took up to
five minutes. The swab was then directly spat into the kit and closed firmly with the stopper.
The saliva samples were kept at the study centre at room temperature for a maximum of four
days before being shipped to the UK and subsequently tested for cotinine at ABS Laboratories,
UK. The samples were frozen at -20 degrees immediately on receipt in the UK and then thawed
for analysis. Cotinine was determined using a validated Liquid chromatography-tandem mass
spectrometry (LC-MS/MS) assay in human saliva using cotinine-d3 to internally standardize
the procedure. The method with a calibration range of 1 to 750 ng/mL was applied to this
study as the samples were from subjects that chewed tobacco. Cotinine was extracted from
human saliva using 50 μL of sample using liquid/liquid extraction with ethyl acetate. The sol-
vent was removed under nitrogen and the extract re-suspended in methanol for quantitative
determination using Hydrophilic interaction liquid chromatography (HILIC) on a Thermo
perfluorinated phenyl (PFP) column using LC-MS/MS with multiple reaction monitoring
(MRM) on an Agilent 1100 LC system interfaced to an ABSciex API 4000 tandem mass spec-
trometer. Analytical acceptance criteria were considered as specified by the Food and Drug
Administration [14].
Determinants of Salivary Cotinine among Smokeless Tobacco Users in Bangladesh
PLOS ONE | DOI:10.1371/journal.pone.0160211 August 9, 2016 3 / 9
Statistical analysis
Exploratory analysis of all variables was performed. Geometric mean was calculated for salivary
cotinine concentration across socio-demographic and tobacco use behaviours. We also
explored whether differences in proportion of tobacco use behaviours exist across sex of the
participants. Simple and multiple linear regression analyses were conducted to compute crude
and adjusted estimates for association of variables with saliva cotinine levels. Assumption of
normality was not met for the bivariate analysis and saliva cotinine levels were positively
Table 1. Tobacco use behaviours of the study participants (n = 200).
Tobacco use behaviour Overall n (%) Male (n = 100) n (%) Female (n = 100) n (%) p-value
Duration of daily ST use † 226 (134) 207 (126) 244 (141) .05
Dips per day † 11.7 (6) 12.8 (6.7) 10.5 (4.4) .004
Quantity of ST use .20
< 20 105 (53) 53 (53) 52 (52)
20–30 74 (37) 33 (33) 41 (41)
>30 21 (11) 14 (14) 7 (7)
Time to ﬁrst chew (TTF) < .001
> 60 mins 74 (37) 50 (50) 24 (24)
31–60 mins 40 (20) 26 (26) 14 (14)
6–30 mins 49 (25) 16 (16) 33 (33)
< 5 minutes 37 (18) 8 (8) 29 (29)
FTND-ST† 4.7 (2.5) 3.7 (2.1) 5.7 (2.4) < .001
TDS based dependence < .001
Yes 117 (59) 77 (77) 40 (40)
No 83 (41) 23 (23) 60 (60)
Swallowing of tobacco juices .04
Never 14 (7) 9 (9) 5 (5)
Sometimes 106 (53) 62 (62) 44 (44)
Always 80 (40) 29 (29) 51 (51)
Urge to use ST .01
Not at all to sometime 22 (11) 17 (17) 5 (5)
A lot of time to all the time 178 (89) 83 (83) 95 (95)
Strength of urges .01
Not at all to sometime 13 (7) 11 (11) 2 (2)
A lot of time to all the time 187 (93) 89 (89) 98 (98)
Past attempts to decrease ST use .01
Yes 43 (22) 14 (14) 29 (29)
No 157 (78) 86 (86) 71 (71)
Past smoking status < .001
Smokers 40 (20) 37 (37) 3 (3)
Never smokers 160 (80) 63 (63) 97 (97)
Type of ST products used < .001
Saada patta/Gul/Khaini 15 (8) 9 (9) 6 (6)
Paan with Zarda 137 (69) 82 (82) 55 (55)
Combination of two or more 48 (24) 9 (9) 39 (39)
Note: FTND-ST = Fagerström Test for Nicotine Dependence–Smokeless Tobacco; TDS based dependence = Tobacco Dependence Screener score of 5 or
more; Quantity of ST use = Grams of ST used per week
† Statistics reported are mean (M) and standard deviation (SD)
doi:10.1371/journal.pone.0160211.t001
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skewed; therefore we applied logarithmic transformation to salivary cotinine levels for statisti-
cal analyses. Regression diagnostics were performed to evaluate multicollinearity and influen-
tial observations. We set the cut off value of Variance Inflation Factor>5 to exclude the factors
from the final model [17]. None of the variables met this criterion. However only those vari-
ables that were significantly associated with cotinine levels in simple linear regression were
included in the final model due to the limited sample size.
All analyses were performed using SAS v.9.4 (SAS Institute Inc. Cary, NC, USA) and a level
of 0.05 was used for statistical significance.
Results
We screened 224 adult ST users for eligibility; out of which 200 were recruited in the study.
The mean age of participants was 46.8 (SD:13.3) and 50% of them were males. The geometric
mean salivary cotinine concentration among these ST users was 380ng/ml. All participants
used ST every day in the past seven days while mean number of DPD was 12 (SD: 6). Table 1
summarizes tobacco use behaviours by sex.
Tables 2 and 3 present parameter estimates and their 95% CIs from simple linear regression
examining associations between ST dependence and participants’ socio-demographic variables
and ST use behaviours, respectively. The analyses suggested that among socio-demographic
characteristics and tobacco use behaviours; education, DPD, duration of daily ST use in
months, types of ST used and TTF and FTND-ST scores were associated with log mean cotin-
ine concentration reaching statistical significance. Variables such as swallowing of tobacco
juices and smoking status were not associated with cotinine concentration.
Multiple linear regression model, presented in Table 4, suggested that DPD was the only sig-
nificant variable while adjusting for duration of daily ST use in months, types of ST products,
TTF, and FTND-ST.
Results suggested that salivary cotinine concentration increased by 0.2 ng/ml (p = 0.04)
with each additional dip of ST per day while holding the effect of other factors constant.
Discussion
This is the first study to describe associations between salivary cotinine concentrations and
socio-demographic characteristics and tobacco use behaviours among ST users in Bangladesh.
We found that ST users in our study have very high levels of cotinine (380ng/ml [GSD:2]) com-
pared to cigarette smokers as found in a previous study [18].
Table 2. Association between socio-demographic characteristics and salivary cotinine concentration*.
Variable n (%) Cotinine † (ng/ml) β-Coefﬁcient (95%CI) Standard Error p–value
Sex
Female 100 (50) 361 Ref .11 .38
Male 100(50) 399 .09 (-.12 to .30)
Education
No formal education 95 (47) 426 Ref
Primary or less 75 (37) 270 .06 (-.29 to .16) .11 .58
Secondary or less 20 (10) 382 -.44 (-.80 to -.07) .18 .02
High secondary or more 12 (6) 401 -.06 (-.43 to .54) .24 .82
SES index .001 (-.004 to .01) .002 .61
* Log transformation of salivary cotinine concentration
†Geographic mean
doi:10.1371/journal.pone.0160211.t002
Determinants of Salivary Cotinine among Smokeless Tobacco Users in Bangladesh
PLOS ONE | DOI:10.1371/journal.pone.0160211 August 9, 2016 5 / 9
Previous studies of ST users have identified distinct tobacco use characteristics associated
with cotinine concentration. Some tobacco use characteristics such as cans of tobacco con-
sumed per week, swallowing of tobacco juice, and past quit attempts were reported to be associ-
ated with cotinine in previous studies [12], [13] but this study could not find such associations.
This study evaluated univariate and multivariate associations between cotinine concentration
and tobacco use characteristics. We found duration of daily ST use in months as the only factor
Table 3. Overall association between ST use behaviors and salivary cotinine concentration* (simple linear regression).
Tobacco use behaviour n (%) Cotinine † (ng/ml) β-Coefﬁcient (95%CI) Standard Error p–value
Duration of daily ST use .001 (.0001 to .002) .00 .02
Dips per day .02 (.01 to .04) .01 .02
Quantity of ST use
< 20 105 (52) 340 Ref - -
20–30 74 (37) 417 .20 (-.03 to .42) .11 .08
> 30 21 (11) 473 .33 (-.02 to (.68) .17 .06
Time to ﬁrst chew (TTF)
> 60 mins 74 (37) 315 Ref - -
31–60 mins 40 (20) 380 .20 (-.09 to .48) .15 .18
6–30 mins 48 (24) 434 .31 (.05 to .58) .14 .02
< 5 minutes 37 (19) 461 .38 (.10 to .68) .14 .01
FTND-ST† .7 .02 .11
TDS based dependence
Yes 117 (59) 375 Ref - -
No 83 (41) 386 .04 (-.17 to .25) .11 .69
Swallowing of tobacco juices
Never 14 (7) 357 Ref - -
Sometimes 106 (53) 355 -.01 (-.42 to .41) .21 .98
Always 80 (40) 419 .15 (-.27 to .58) .21 .48
Urge to use ST
Not at all to sometime 22 (11) 340 Ref - -
A lot of time to all the time 178 (81) 385 .12 (-.21 to .45) .17 .48
Strength of urges
Not at all to sometime 13 (7) 374 Ref - -
A lot of time to all the time 187 (93) 380 .01 (-.41 to .43) .21 .96
Past attempts to decrease ST use
Yes 43 (21) 318 Ref - -
No 157 (79) 398 .22 (-.03 to .47) .13 .08
Past smoking status
Smokers 40 (20) 390 Ref - -
Never smokers 160 (80) 377 -.03 (-.30 to .22) .13 .76
Type of ST products used
Saada patta/Gul/Khaini 15 (7) 338 Ref - -
Paan with Zarda 137 (68) 349 .23 (-.17 to .62) .20 .26
Combination of two or more 50 (25) 460 .26 (.02 to .51) .12 .04
Note: FTND-ST = Fagerström Test for Nicotine Dependence–Smokeless Tobacco; TDS based dependence = Tobacco Dependence Screener score of 5 or
more; Quantity of ST use = Grams of ST used per week
* Log transformation of salivary cotinine concentration
†Geographic mean
doi:10.1371/journal.pone.0160211.t003
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to have an independent significant association with salivary cotinine. Similar association was
found in a past study of regular ST users in the US [19]. The differences in findings of this
study may be attributable to the variations in the populations across studies. Most importantly
some of the topographic factors such as swallowing of tobacco juice and quantity of ST use
(cans/pouches) are product specific, therefore, these may not be applicable to the distinct ST
product types used by Bangladeshi ST users.
Cotinine is a recommended biomarker to measure dependence among ST users [20]. Past
studies of ST dependence have shown inconsistent association between cotinine concentration
and dependence measures based on Fagerström Tolerance Questionnaire (FTQ). However,
results of the current study found significant association between FTND-ST and cotinine con-
centration, which are similar to the findings of the past studies of FTND-ST among ST users
[21], [22]. Similarly, TTF, which is a brief measure of dependence and has been widely used in
cigarette dependence studies, was also positively associated with cotinine concentration. These
findings indicate concurrent validity of cotinine concentration as a measure of dependence
among ST users.
There are a few limitations of this study including sample selection from urban areas only
and potential recall bias. Earlier studies showed notable variation in type of ST use and con-
sumption pattern among urban and rural ST users in Bangladesh [23]. As ST users were
selected from urban areas only, it limits the generalizability of the study results. However, to
capture the socio-economic dissimilarity among users, we recruited users from both slum and
non-slum areas in Dhaka city. The self-reported questionnaire survey might also result in mea-
surement error due to under or over estimation while reporting ST consumption by type and
quantity. However, if it had occurred, there would be non-differential misclassification result-
ing in more conservative findings. Despite a comprehensive evaluation of ST use characteris-
tics, we did not include some of the tobacco use variables such as, dip duration, age of onset of
ST use, age regular ST use, initial intent of ST use, and ST use to quit smoking.
High cotinine concentration among ST users and increased prevalence of ST use in Bangla-
desh [6] indicate that ST products are highly addictive and ST users need adequate support to
give up this behaviour. As Bangladesh lacks comprehensive tobacco control programmes there
is an urgent need to design and implement effective interventions to create awareness and
Table 4. Adjusted association between ST use behaviours and salivary cotinine concentration* (multiple linear regression).
Tobacco use behaviour β-Coefﬁcient (95%CI) Standard Error p–value
Duration of daily ST use .001 .00 .15
Dips per day .02 .01 .03
Time to ﬁrst chew (TTF)
> 60 mins Ref
31–60 mins .10 .15 .49
6–30 mins .21 .19 .28
< 5 minutes .16 .24 .51
FTND-ST† .01 .00 .79
Type of ST products used
Saada patta/Gul/Khaini Ref
Paan with Zarda .07 .21 .8
Combination of two or more .11 .14 .5
* Log transformation of salivary cotinine concentration
†Geographic mean
doi:10.1371/journal.pone.0160211.t004
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provide quit support to ST users. Further study on ST consumption among youth, groups at
highest risk and cessation success are important to better inform tobacco control initiatives
that would effectively reduce burden of harm attributable to ST use. First step to achieve these
goals will be to regulate the production and supply of all ST products used in the country.
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